Overview

Smoking Cessation & Opioid Dependence Treatment Integration

Status:
Completed
Trial end date:
2017-04-10
Target enrollment:
Participant gender:
Summary
The primary purpose of this study was to examine the feasibility of integrating a smoking cessation intervention for cigarette smokers enrolled in an outpatient program for opioid dependence. The secondary purpose was to compare treatment effects as a function of phase in the outpatient program: 0-90 days (weekly attendance), 90 days-1 year (biweekly attendance), and more than 1 year (monthly attendance).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
West Virginia University
Collaborators:
National Institute on Drug Abuse (NIDA)
Pfizer
Treatments:
Varenicline